SCREAMING EAGLE ACQ -CLASS A (SCRM) Fundamental Analysis & Valuation

NASDAQ:SCRM • KYG794071053

Current stock price

10.18 USD
-0.96 (-8.62%)
At close:
10.3 USD
+0.12 (+1.18%)
After Hours:

This SCRM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. SCRM Profitability Analysis

1.1 Basic Checks

  • SCRM had positive earnings in the past year.
  • SCRM had a negative operating cash flow in the past year.
SCRM Yearly Net Income VS EBIT VS OCF VS FCFSCRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 10M -10M 20M -20M

1.2 Ratios

Industry RankSector Rank
ROA 2.1%
ROE 2.24%
ROIC N/A
ROA(3y)1.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SCRM Yearly ROA, ROE, ROICSCRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 1 -1 2 -2 3

1.3 Margins

  • SCRM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SCRM Yearly Profit, Operating, Gross MarginsSCRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. SCRM Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, SCRM has about the same amount of shares outstanding.
  • SCRM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SCRM Yearly Shares OutstandingSCRM Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M 80M
SCRM Yearly Total Debt VS Total AssetsSCRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 200M 400M 600M

2.2 Solvency

  • SCRM has an Altman-Z score of 5.49. This indicates that SCRM is financially healthy and has little risk of bankruptcy at the moment.
  • There is no outstanding debt for SCRM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.49
ROIC/WACCN/A
WACCN/A
SCRM Yearly LT Debt VS Equity VS FCFSCRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 36.26 indicates that SCRM has no problem at all paying its short term obligations.
  • SCRM has a Quick Ratio of 36.26. This indicates that SCRM is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 36.26
Quick Ratio 36.26
SCRM Yearly Current Assets VS Current LiabilitesSCRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. SCRM Growth Analysis

3.1 Past

  • SCRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.03%.
EPS 1Y (TTM)-24.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-283.45%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. SCRM Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 53.58 indicates a quite expensive valuation of SCRM.
  • When comparing the Price/Earnings ratio of SCRM to the average of the S&P500 Index (26.77), we can say SCRM is valued expensively.
Industry RankSector Rank
PE 53.58
Fwd PE N/A
SCRM Price Earnings VS Forward Price EarningsSCRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SCRM Per share dataSCRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SCRM Dividend Analysis

5.1 Amount

  • SCRM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

SCRM Fundamentals: All Metrics, Ratios and Statistics

SCREAMING EAGLE ACQ -CLASS A

NASDAQ:SCRM (5/13/2024, 8:00:02 PM)

After market: 10.3 +0.12 (+1.18%)

10.18

-0.96 (-8.62%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners3.4%
Inst Owner Change0%
Ins Owners3.69%
Ins Owner Change0%
Market Cap365.77M
Revenue(TTM)N/A
Net Income(TTM)16.71M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 53.58
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.49
EV/EBITDA N/A
EPS(TTM)0.19
EY1.87%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS20.8
TBVpS20.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 2.1%
ROE 2.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 36.26
Quick Ratio 36.26
Altman-Z 5.49
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-283.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1399.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.08%
OCF growth 3YN/A
OCF growth 5YN/A

SCREAMING EAGLE ACQ -CLASS A / SCRM Fundamental Analysis FAQ

What is the fundamental rating for SCRM stock?

ChartMill assigns a fundamental rating of 2 / 10 to SCRM.


Can you provide the valuation status for SCREAMING EAGLE ACQ -CLASS A?

ChartMill assigns a valuation rating of 0 / 10 to SCREAMING EAGLE ACQ -CLASS A (SCRM). This can be considered as Overvalued.


Can you provide the profitability details for SCREAMING EAGLE ACQ -CLASS A?

SCREAMING EAGLE ACQ -CLASS A (SCRM) has a profitability rating of 0 / 10.


What are the PE and PB ratios of SCREAMING EAGLE ACQ -CLASS A (SCRM) stock?

The Price/Earnings (PE) ratio for SCREAMING EAGLE ACQ -CLASS A (SCRM) is 53.58 and the Price/Book (PB) ratio is 0.49.